Results 71 to 80 of about 284 (126)

Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension

, 2019
Markus Rey, Markus Kramberg, Martine Clozel, Enrico Vezzali, Joël Ménard, Marc Iglarz, Céline Bortolamiol, Daniel S. Strasser, Stéphane Delahaye, Patrick Hess, Ulrich Mentzel, Frederic Trensz, Daniel Wanner, Hakim Hadana   +13 more
core   +1 more source

Progress in mechanistic and clinical translational research of endothelin A receptor antagonists in the treatment of diabetic kidney disease: a narrative review. [PDF]

Front Endocrinol (Lausanne)
Li M, Xie C, Qiu Y, Li X, Han G, Ma N, Wang G.   +6 more
europepmc   +1 more source

Resistant Hypertension: Integration of Novel Agents and Interventional Approaches in Clinical Practice. [PDF]

Rev Cardiovasc Med
Arriola-Montenegro J, Chaponan-Lavalle A, Nombera-Aznaran N, Abdalla M, Bizer B, Mohan A, Muñoz Verdugo IA, Zardoost P, Ordaya-Gonzales K, Villarreal Rizzo A, Rios-Garcia W, Yip LKY, Gonzalez Suarez ML.   +12 more
europepmc   +1 more source

Structural and Pharmacological Characterization of AT-121 Reveals Carbonic Anhydrase Inhibition as a Complementary Mechanism to Dual MOR/NOR Agonism. [PDF]

ACS Med Chem Lett
Bonardi A, Ferraroni M, Gratteri P, Supuran CT, Angeli A.   +4 more
europepmc   +1 more source

Highlights on U.S. FDA-approved halogen-containing drugs in 2024. [PDF]

Eur J Med Chem
Ali S, Tian X, Meccia SA, Zhou J.
europepmc   +1 more source

Endothelin-1 signaling in the kidney: recent advances and remaining gaps. [PDF]

Am J Physiol Renal Physiol
Brooks AJ, Gallego-López MDC, De Miguel C.   +2 more
europepmc   +1 more source

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024. [PDF]

Eur Heart J Cardiovasc Pharmacother
Tamargo J, Agewall S, Ambrosio G, Borghi C, Cerbai E, Dan GA, Drexel H, Ferdinandy P, Grove EL, Klingenberg R, Morais J, Parker W, Rocca B, Sulzgruber P, Semb AG, Sossalla S, Kaski JC, Dobrev D.   +17 more
europepmc   +1 more source

Aprocitentan: a novel option for treatment of resistant arterial hypertension

Polish Archives of Internal Medicine
openaire   +2 more sources

Emerging Pharmacological Approaches for the Treatment of Arterial Hypertension. [PDF]

Biomedicines
Schinzari F, Montenero R, Cardillo C, Tesauro M.   +3 more
europepmc   +1 more source

Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage. [PDF]

Int J Mol Sci
Nguyen M, Oh S, King M, Yu W, Ramadan AR.   +4 more
europepmc   +1 more source